These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16596242)

  • 1. 18FDG PET in oncology: the best and the worst (Review).
    Belhocine T; Spaepen K; Dusart M; Castaigne C; Muylle K; Bourgeois P; Bourgeois D; Dierickx L; Flamen P
    Int J Oncol; 2006 May; 28(5):1249-61. PubMed ID: 16596242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer.
    Muylle K; Castaigne C; Flamen P
    Curr Opin Oncol; 2005 May; 17(3):249-53. PubMed ID: 15818169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].
    Ruiz Hernández G; Romero de Avila Y Avalos C; Carreras Delgado JL
    Med Clin (Barc); 2005 Feb; 124(6):229-36. PubMed ID: 15737307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic monitoring of chemosensitivity with 18FDG PET.
    Jerusalem G; Belhocine TZ
    Methods Mol Med; 2005; 111():417-40. PubMed ID: 15911993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of PET for evaluation of treatment response in oncology].
    Bourguet P
    Cancer Radiother; 2006 Nov; 10(6-7):334-7. PubMed ID: 16950641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
    Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
    Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification in clinical fluorodeoxyglucose positron emission tomography.
    Hallett WA
    Nucl Med Commun; 2004 Jul; 25(7):647-50. PubMed ID: 15208490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET-CT in oncology.
    Purandare NC; Rangarajan V
    J Postgrad Med; 2010; 56(2):103-8. PubMed ID: 20622389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
    Hoekstra CJ; Stroobants SG; Smit EF; Vansteenkiste J; van Tinteren H; Postmus PE; Golding RP; Biesma B; Schramel FJ; van Zandwijk N; Lammertsma AA; Hoekstra OS
    J Clin Oncol; 2005 Nov; 23(33):8362-70. PubMed ID: 16293866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with 18f-fluoro-deoxy-glucose positron emission tomography/computed tomography in pediatric oncology patients.
    Odalović S; Sobić-Saranović D; Pavlović S; Grozdić I; Saranović D; Petrović M; Milovanović A; Petrasinović Z; Djurić-Stefanović A; Obradović V
    Acta Chir Iugosl; 2011; 58(4):67-73. PubMed ID: 22519195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
    Pelosi E; Deandreis D
    Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography: clinical applications in oncology. Part 1.
    Kumar R; Nadig MR; Chauhan A
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential usefulness of 18F-2-fluoro-deoxy-D-glucose positron emission tomography in cervical compressive myelopathy.
    Baba H; Uchida K; Sadato N; Yonekura Y; Kamoto Y; Maezawa Y; Furusawa N; Abe Y
    Spine (Phila Pa 1976); 1999 Jul; 24(14):1449-54. PubMed ID: 10423790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]-fluoro-D-glucose (18FDG) in a patient with cutaneous T-cell lymphoma.
    Mahmood S; Martínez de Llano SR
    Rev Esp Med Nucl; 2007; 26(5):306. PubMed ID: 17910841
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical applications of positron emission tomography in sarcoma management.
    Quak E; van de Luijtgaarden AC; de Geus-Oei LF; van der Graaf WT; Oyen WJ
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):195-204. PubMed ID: 21342039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
    Culverwell AD; Scarsbrook AF; Chowdhury FU
    Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
    Chowdhury FU; Bradley KM; Gleeson FV
    Clin Radiol; 2008 Dec; 63(12):1297-309. PubMed ID: 18996259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.